Clinical trial
Lorazepam for the Treatment of Status Epilepticus in Children
NCT00114569 · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH · Completed
Key facts
| NCT number | NCT00114569 |
|---|---|
| Title | Lorazepam for the Treatment of Status Epilepticus in Children |
| Official title | Use of Lorazepam for the Treatment of Status Epilepticus |
| Lead sponsor | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH |
| Collaborators | The Emmes Company, LLC Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Status Epilepticus |
| Intervention type | Drug |
| Interventions | lorazepam |
| Enrollment | 69 |
| Start date | Mar 1, 2005 |
| Primary completion | Apr 1, 2007 |
| Completion | Feb 1, 2009 |
| First posted | Jun 16, 2005 |
| Last update posted | May 23, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: